These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 8895234)

  • 1. Continuous co-administration of dextromethorphan or MK-801 with morphine: attenuation of morphine dependence and naloxone-reversible attenuation of morphine tolerance.
    Manning BH; Mao J; Frenk H; Price DD; Mayer DJ
    Pain; 1996 Sep; 67(1):79-88. PubMed ID: 8895234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antinociceptive potentiation and attenuation of tolerance by intrathecal co-infusion of magnesium sulfate and morphine in rats.
    McCarthy RJ; Kroin JS; Tuman KJ; Penn RD; Ivankovich AD
    Anesth Analg; 1998 Apr; 86(4):830-6. PubMed ID: 9539610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of MK 801 on morphine physical dependence: attenuation and intensification.
    Koyuncuoğlu H; Dizdar Y; Aricioğlu F; Sayin U
    Pharmacol Biochem Behav; 1992 Oct; 43(2):487-90. PubMed ID: 1438485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-treatment with MK-801 potentiates naloxone-precipitated morphine withdrawal in the isolated spinal cord of the neonatal rat.
    Bell JA; Beglan CL
    Eur J Pharmacol; 1995 Dec; 294(1):297-301. PubMed ID: 8788444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of the NMDA receptor antagonist, dizocilpine (MK-801), on the development of morphine dependence.
    Makimura M; Sugimoto H; Shinomiya K; Kabasawa Y; Fukuda H
    J Toxicol Sci; 1996 May; 21(2):135-41. PubMed ID: 8780997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The NMDA receptor antagonist MK-801 differentially modulates mu and kappa opioid actions in spinal cord in vitro.
    Feng J; Kendig JJ
    Pain; 1996 Aug; 66(2-3):343-9. PubMed ID: 8880858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of glutamate receptors within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats.
    Watanabe T; Nakagawa T; Yamamoto R; Maeda A; Minami M; Satoh M
    Jpn J Pharmacol; 2002 Apr; 88(4):399-406. PubMed ID: 12046982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of LY293558, an AMPA receptor antagonist, on acute and chronic morphine dependence.
    McLemore GL; Kest B; Inturrisi CE
    Brain Res; 1997 Dec; 778(1):120-6. PubMed ID: 9462883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of morphine dependence and withdrawal by glycine B site antagonists in rats.
    Kotlińska J
    Pharmacol Biochem Behav; 2001 Jan; 68(1):157-61. PubMed ID: 11274720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of morphine withdrawal by the NMDA receptor antagonist MK-801 in rat is age-dependent.
    Zhu H; Barr GA
    Synapse; 2001 Jun; 40(4):282-93. PubMed ID: 11309844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repetitive opioid abstinence causes progressive hyperalgesia sensitive to N-methyl-D-aspartate receptor blockade in the rat.
    Dunbar SA; Pulai IJ
    J Pharmacol Exp Ther; 1998 Feb; 284(2):678-86. PubMed ID: 9454814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dextromethorphan attenuates morphine withdrawal syndrome in neonatal rats passively exposed to morphine.
    Yeh GC; Tao PL; Chen JY; Lai MC; Gao FS; Hu CL
    Eur J Pharmacol; 2002 Oct; 453(2-3):197-202. PubMed ID: 12398904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethanol attenuation of morphine dependence: comparison to dizocilpine.
    Shoemaker WJ; Kosten TA; Muly SM
    Psychopharmacology (Berl); 1997 Nov; 134(1):83-7. PubMed ID: 9399370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of ionotropic glutamatergic transmission in the ventral tegmental area attenuates the physical signs of morphine withdrawal in rats.
    Wang HL; Zhao Y; Xiang XH; Wang HS; Wu WR
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Nov; 28(7):1079-87. PubMed ID: 15610920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of naloxone-induced withdrawal signs by dextromethorphan in morphine-dependent mice.
    Farzin D
    Eur J Pharmacol; 1999 Jul; 377(1):35-42. PubMed ID: 10448923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dextromethorphan potentiates morphine antinociception at the spinal level in rats.
    Chow LH; Huang EY; Ho ST; Lee TY; Tao PL
    Can J Anaesth; 2004 Nov; 51(9):905-10. PubMed ID: 15525615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focal kappa-opioid receptor-mediated dependence and withdrawal in the nucleus paragigantocellularis.
    Sinchaisuk S; Ho IK; Rockhold RW
    Pharmacol Biochem Behav; 2002 Dec; 74(1):241-52. PubMed ID: 12376173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethanol enhances naloxone sensitization and disrupts morphine discrimination--comparison to dizocilpine and pentobarbital: explanation of enhancing acute and attenuating chronic effects.
    Kosten TA; Bombace JC
    Prog Neuropsychopharmacol Biol Psychiatry; 2001 Aug; 25(6):1283-306. PubMed ID: 11474846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral administration of dextromethorphan prevents the development of morphine tolerance and dependence in rats.
    Mao J; Price DD; Caruso FS; Mayer DJ
    Pain; 1996 Oct; 67(2-3):361-8. PubMed ID: 8951930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dopamine D3/2 agonist 7-OH-DPAT attenuates the development of morphine tolerance but not physical dependence in rats.
    Cook CD; Barrett AC; Syvanthong C; Picker MJ
    Psychopharmacology (Berl); 2000 Sep; 152(1):93-104. PubMed ID: 11041321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.